Sio Gene Therapies Inc (SIOX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 12-2022 | 09-2022 | 06-2022 | 03-2022 | 12-2021 | |
| Operating Expenses | 4,483 | 3,277 | 8,534 | 13,076 | 25,373 |
| Operating Income | -4,483 | -3,277 | -8,534 | -13,076 | -25,373 |
| Other Income | 464 | 197 | 124 | 39 | -83 |
| Pre-tax Income | -4,019 | -3,080 | -8,410 | -13,037 | -25,456 |
| Income Tax | N/A | N/A | -4 | 287 | N/A |
| Net Income Continuous | -4,019 | -3,080 | -8,406 | -13,324 | -25,456 |
| Net Income | $-4,019 | $-3,080 | $-8,406 | $-13,324 | $-25,456 |
| EPS Basic Total Ops | -0.05 | -0.04 | -0.11 | -0.18 | -0.35 |
| EPS Basic Continuous Ops | -0.05 | -0.04 | -0.11 | -0.18 | -0.35 |
| EPS Diluted Total Ops | -0.05 | -0.04 | -0.11 | -0.18 | -0.35 |
| EPS Diluted Continuous Ops | -0.05 | -0.04 | -0.11 | -0.18 | -0.35 |
| EPS Diluted Before Non-Recurring Items | -0.05 | -0.04 | -0.11 | N/A | -0.35 |
| EBITDA(a) | $-4,483 | $-3,411 | $-8,263 | $-12,597 | $-25,308 |